Back to Search
MICHAEL KAGEN, M.D.
M.D.
Internal Medicine Physician
NPI: 1528352721Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
10137232-1205(UT)
Research & Publications (12)
Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.
PMID 18239614·J Invest Dermatol·2008
3-trial
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin.
PMID 15380528·Clin Immunol·2004
8-other
Squamous cell carcinoma of the cervix metastatic to the skin.
PMID 11423850·J Am Acad Dermatol·2001
5-case
Multiple infundibulocystic basal cell carcinomas in association with human immunodeficiency virus.
PMID 10885410·J Cutan Pathol·2000
5-case
Calcinosis cutis following the administration of intravenous calcium therapy.
PMID 10795076·Cutis·2000
5-case
Wrinkling due to mid-dermal elastolysis: two cases and literature review.
PMID 10689227·J Cutan Med Surg·2000
5-case
The ABC rule for clinical detection of subungual melanoma.
PMID 10642684·J Am Acad Dermatol·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4580 SILVER SPRINGS DR STE 150
PARK CITY, UT 84098 - Phone
- (435) 633-6263
Quick Facts
- NPI
- 1528352721
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile